6.
Hill M, Yang Y, Zhang L, Sun Z, Jia G, Parrish A
. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021; 119:154766.
DOI: 10.1016/j.metabol.2021.154766.
View
7.
Sozmen K, Unal B
. Prevalence of low ankle brachial index and relationship with cardiovascular risk factors in a Western urban population in Turkey. Angiology. 2012; 65(1):43-50.
DOI: 10.1177/0003319712466581.
View
8.
Makdisse M, Pereira A, Brasil D, Borges J, Machado-Coelho G, Krieger J
. Prevalence and risk factors associated with peripheral arterial disease in the Hearts of Brazil Project. Arq Bras Cardiol. 2009; 91(6):370-82.
DOI: 10.1590/s0066-782x2008001800008.
View
9.
Criqui M, Matsushita K, Aboyans V, Hess C, Hicks C, Kwan T
. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation. 2021; 144(9):e171-e191.
PMC: 9847212.
DOI: 10.1161/CIR.0000000000001005.
View
10.
Alexandre T, Scholes S, Santos J, de Oliveira Duarte Y, de Oliveira C
. The combination of dynapenia and abdominal obesity as a risk factor for worse trajectories of IADL disability among older adults. Clin Nutr. 2017; 37(6 Pt A):2045-2053.
PMC: 6013360.
DOI: 10.1016/j.clnu.2017.09.018.
View
11.
Zhang L, Wang Z, Wang X, Chen Z, Shao L, Tian Y
. Prevalence of Abdominal Obesity in China: Results from a Cross-Sectional Study of Nearly Half a Million Participants. Obesity (Silver Spring). 2019; 27(11):1898-1905.
DOI: 10.1002/oby.22620.
View
12.
Li C, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S
. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022; 13(2):781-794.
PMC: 8977978.
DOI: 10.1002/jcsm.12901.
View
13.
Uchida S, Kamiya K, Hamazaki N, Nozaki K, Ichikawa T, Nakamura T
. Prognostic utility of dynapenia in patients with cardiovascular disease. Clin Nutr. 2021; 40(4):2210-2218.
DOI: 10.1016/j.clnu.2020.09.050.
View
14.
Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K
. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2.
DOI: 10.1016/j.jamda.2019.12.012.
View
15.
Zang H, Shi H, Speroff L
. Low-dose hormone therapy in postmenopausal women in China. Climacteric. 2009; 13(6):544-52.
DOI: 10.3109/13697130903395201.
View
16.
Aday A, Matsushita K
. Epidemiology of Peripheral Artery Disease and Polyvascular Disease. Circ Res. 2021; 128(12):1818-1832.
PMC: 8202714.
DOI: 10.1161/CIRCRESAHA.121.318535.
View
17.
Ma Y, Fu L, Jia L, Han P, Kang L, Yu H
. Muscle strength rather than muscle mass is associated with osteoporosis in older Chinese adults. J Formos Med Assoc. 2017; 117(2):101-108.
DOI: 10.1016/j.jfma.2017.03.004.
View
18.
McDermott M, Tian L, Ferrucci L, Liu K, Guralnik J, Liao Y
. Associations between lower extremity ischemia, upper and lower extremity strength, and functional impairment with peripheral arterial disease. J Am Geriatr Soc. 2008; 56(4):724-9.
PMC: 2645633.
DOI: 10.1111/j.1532-5415.2008.01633.x.
View
19.
Kuo H, Yu Y
. The relation of peripheral arterial disease to leg force, gait speed, and functional dependence among older adults. J Gerontol A Biol Sci Med Sci. 2008; 63(4):384-90.
DOI: 10.1093/gerona/63.4.384.
View
20.
Fonseca Alves D, Bartholomeu-Neto J, Rodrigues Junior E, Ribeiro Zarricueta B, Nobrega O, Cordova C
. Walking Speed, Risk Factors, and Cardiovascular Events in Older Adults-Systematic Review. J Strength Cond Res. 2017; 31(11):3235-3244.
DOI: 10.1519/JSC.0000000000002182.
View